Strategic dependencies on raw materials like solvents and reagents are often buried deep within supply chains, making them difficult to diversify during an active crisis. The traditional definition of national security is undergoing a radical transformation as the world becomes increasingly
The ongoing fragmentation of the drug pricing market forces patients to decide if immediate cash savings are worth losing progress toward their out-of-pocket maximums. As the American healthcare landscape evaluates the six-month performance of TrumpRx, a high-profile prescription drug pricing
Many modern health systems have evolved into financial services enterprises with hospitals attached, prioritizing capital accumulation over their original charitable missions. This fundamental shift marks a departure from the mid-20th-century ideal of the community infirmary, which functioned
Emergency preparedness experts emphasize the need for medical countermeasures that can be easily distributed to civilian populations following a nuclear accident. This clinical necessity drove researchers at the Fralin Biomedical Research Institute at VTC to develop XOlacta, an experimental oral
The biological phenomenon of first-pass metabolism can completely neutralize a drug before it reaches systemic circulation, making early metabolic profiling a critical developmental milestone. Beyond this initial barrier, the intricate dance of absorption, distribution, metabolism, and
Pfizer’s torcetrapib serves as a stark reminder that hitting a specific biological target and improving biomarkers does not always translate into positive clinical outcomes for patients. This cautionary tale looms larger than ever in the current landscape, where the pharmaceutical industry finds
